Chao; Hannguang J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chao; Hannguang J..The latest application filed is for "apelin receptor agonists and methods of use".

Company Profile

3.10.13

Chao; Hannguang J. - Nashua NH
Chao; Hannguang J. - Lawrenceville NJ
Chao; Hannguang J. - Pennington NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Apelin receptor agonists and methods of use Grant 11,390,616 - Meng , et al. July 19, 2	2022-07-19
Apelin Receptor Agonists And Methods Of Use App 20210198246 - Meng; Wei ; et al.	2021-07-01
2-(1,1'-biphenyl)-1h-benzodimidazole Derivatives And Related Compounds As Apelin And Apj Agonists For Treating Cardiovascular Di App 20200231547 - Su; Shun ; et al.	2020-07-23
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists App 20190263791 - Johnson; James A. ; et al.	2019-08-29
2,4-dihydroxy-nicotinamides as APJ agonists Grant 10,392,347 - Kim , et al. A	2019-08-27
2,4-dihydroxy-nicotinamides As Apj Agonists App 20180297954 - Kim; Soong-Hoon ; et al.	2018-10-18
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists App 20180273518 - Johnson; James A. ; et al.	2018-09-27
4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists Grant 10,011,594 - Johnson , et al. July 3, 2	2018-07-03
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists App 20160355507 - Johnson; James A. ; et al.	2016-12-08
Linear urea mimics antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic condition Grant 7,816,382 - Chao , et al. October 19, 2	2010-10-19
LXR modulators Grant 7,741,317 - Chao , et al. June 22, 2	2010-06-22
Urea antagonists of P2Y.sub.1receptor useful in the treatment of thrombotic conditions Grant 7,674,828 - Chao , et al. March 9, 2	2010-03-09
Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions Grant 7,550,499 - Tuerdi , et al. June 23, 2	2009-06-23
Urea Antagonists Of P2y1 Receptor Useful In The Treatment Of Thrombotic Conditions App 20080280905 - Chao; Hannguang J. ; et al.	2008-11-13
Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions Grant 7,388,021 - Chao , et al. June 17, 2	2008-06-17
Compounds useful as motilin agonists and method Grant 7,338,954 - Li , et al. March 4, 2	2008-03-04
Compounds useful as motilin agonists and method Grant 7,262,195 - Li , et al. August 28, 2	2007-08-28
LXR modulators App 20070093470 - Chao; Hannguang J. ; et al.	2007-04-26
Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition App 20070004677 - Chao; Hannguang J. ; et al.	2007-01-04
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions App 20050267119 - Chao, Hannguang J. ; et al.	2005-12-01
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions App 20050261244 - Tuerdi, Huji ; et al.	2005-11-24
Compounds useful as motilin agonists and method App 20050080116 - Li, James J. ; et al.	2005-04-14
Compounds useful as motilin agonists and method App 20050065156 - Li, James J. ; et al.	2005-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.